These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 18035747)

  • 21. Effects of autologous stem cells on immunohistochemical patterns and gene expression of metalloproteinases and their tissue inhibitors in doxorubicin cardiomyopathy in a rabbit model.
    Aupperle H; Garbade J; Schubert A; Barten M; Dhein S; Schoon HA; Mohr FW
    Vet Pathol; 2007 Jul; 44(4):494-503. PubMed ID: 17609194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of myogenic microRNAs in sub-chronic but not in sub-acute model of daunorubicin-induced cardiomyopathy.
    Doka G; Malikova E; Galkova K; La Rocca G; Kruzliak P; Adamek M; Rodrigo L; Krenek P; Klimas J
    Mol Cell Biochem; 2017 Aug; 432(1-2):79-89. PubMed ID: 28303410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac energetics in daunorubicin-induced cardiomyopathy.
    Gibbs CL; Woolley G; Kotsanas G; Gibson WR
    J Mol Cell Cardiol; 1984 Oct; 16(10):953-62. PubMed ID: 6512865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.
    Van Linthout S; Seeland U; Riad A; Eckhardt O; Hohl M; Dhayat N; Richter U; Fischer JW; Böhm M; Pauschinger M; Schultheiss HP; Tschöpe C
    Basic Res Cardiol; 2008 Jul; 103(4):319-27. PubMed ID: 18347835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of daunorubicin cardiotoxicity prevention with pyridoxal isonicotinoyl hydrazone in rabbits.
    Simůnek T; Klimtová I; Kaplanová J; Sterba M; Mazurová Y; Adamcová M; Hrdina R; Gersl V; Ponka P
    Pharmacol Res; 2005 Mar; 51(3):223-31. PubMed ID: 15661572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis.
    Friehs I; Margossian RE; Moran AM; Cao-Danh H; Moses MA; del Nido PJ
    Basic Res Cardiol; 2006 May; 101(3):204-13. PubMed ID: 16369727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy].
    Pauschinger M; Chandrasekharan K; Li J; Schwimmbeck PL; Noutsias M; Schultheiss HP
    Herz; 2002 Nov; 27(7):677-82. PubMed ID: 12439639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy.
    Tyagi SC; Kumar SG; Haas SJ; Reddy HK; Voelker DJ; Hayden MR; Demmy TL; Schmaltz RA; Curtis JJ
    J Mol Cell Cardiol; 1996 Jul; 28(7):1415-28. PubMed ID: 8841929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of new antineoplastic agents (dimethoxybenflurone and Oracin) on the cardiovascular system and other parameters in the rabbit in vivo].
    Machácková J; Gersl V; Adamcová M; Mazurová Y; Hrdina R; Mĕlka M; Nobilis M
    Acta Medica (Hradec Kralove) Suppl; 2000; 43(2):119-38. PubMed ID: 11413675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IGF-I in experimental daunorubicin-induced cardiomyopathy in rabbits.
    Gersl V; Cerman J; Suba P; Mazurová Y; Hrdina R; Machácková J
    Hum Exp Toxicol; 1999 Mar; 18(3):154-61. PubMed ID: 10215105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of glycosaminoglycans on matrix metalloproteinases in type II collagen-induced experimental arthritis.
    Sandya S; Sudhakaran PR
    Exp Biol Med (Maywood); 2007 May; 232(5):629-37. PubMed ID: 17463159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative cardiac and renal toxicity of daunorubicin in the rat and rabbit.
    Deprez-DeCampeneere D; Jaenke R; Trouet A
    Cancer Treat Rep; 1982 Feb; 66(2):395-7. PubMed ID: 7055822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity.
    Sterba M; Popelová O; Simunek T; Mazurová Y; Potácová A; Adamcová M; Kaiserová H; Ponka P; Gersl V
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1336-47. PubMed ID: 17003229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of matrix metalloproteinases, type IV collagen, and interleukin-10 in rabbits treated with morphine after lamellar keratectomy.
    Ribeiro AP; Silva ML; Araújo RL; Ferrucci DL; Mineo T; Thiesen R; Bandarra MB; Laus JL
    Vet Ophthalmol; 2012 May; 15(3):153-63. PubMed ID: 22059930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of oxidative stress and remodeling by cardiac inhibitor of metalloproteinase protein transfer.
    Cox MJ; Hawkins UA; Hoit BD; Tyagi SC
    Circulation; 2004 May; 109(17):2123-8. PubMed ID: 15117845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel approaches to retard ventricular remodeling in heart failure.
    Spinale FG
    Eur J Heart Fail; 1999 Mar; 1(1):17-23. PubMed ID: 10937974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study.
    González AA; Segura AM; Horiba K; Qian S; Yu ZX; Stetler-Stevenson W; Willerson JT; McAllister HA; Ferrans VJ
    Hum Pathol; 2002 Dec; 33(12):1158-64. PubMed ID: 12514782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced gene expression of myocardial matrix metalloproteinases 2 and 9 after acute treatment with doxorubicin in mice.
    Kizaki K; Ito R; Okada M; Yoshioka K; Uchide T; Temma K; Mutoh K; Uechi M; Hara Y
    Pharmacol Res; 2006 Apr; 53(4):341-6. PubMed ID: 16455267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload.
    Janicki JS; Brower GL; Gardner JD; Forman MF; Stewart JA; Murray DB; Chancey AL
    Cardiovasc Res; 2006 Feb; 69(3):657-65. PubMed ID: 16376324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tumor necrosis factor alpha and myocardial matrix metalloproteinases in left ventricular remodeling].
    Wang XM; Yang LX; Zhu SJ; Yang YJ; Guo CM; Qi F; Wei L; Shi YK; Wang Y; Ren L
    Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):828-31. PubMed ID: 15634542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.